{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "TWD", "esgPopulated": false, "market": "tw_market", "longName": "MegaPro Biomedical Co., Ltd", "marketState": "POSTPOST", "regularMarketPrice": 26.95, "messageBoardId": "finmb_568209385", "exchange": "TWO", "shortName": "MPB", "exchangeTimezoneShortName": "CST", "exchangeTimezoneName": "Asia/Taipei", "regularMarketChangePercent": -0.18518236, "gmtOffSetMilliseconds": 28800000, "fiftyTwoWeekLowChange": 11.050001, "fiftyTwoWeekLowChangePercent": 0.69496864, "fiftyTwoWeekRange": "15.9 - 30.75", "fiftyTwoWeekHighChange": -3.7999992, "fiftyTwoWeekHighChangePercent": -0.12357721, "fiftyTwoWeekLow": 15.9, "fiftyTwoWeekHigh": 30.75, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.02, "firstTradeDateMilliseconds": 1634605200000, "priceHint": 2, "regularMarketChange": -0.049999237, "regularMarketTime": 1684133904, "regularMarketDayHigh": 27.0, "regularMarketDayRange": "26.3 - 27.0", "regularMarketDayLow": 26.3, "regularMarketVolume": 46249, "regularMarketPreviousClose": 27.0, "bid": 26.4, "ask": 26.55, "fullExchangeName": "Taipei Exchange", "regularMarketOpen": 26.5, "averageDailyVolume3Month": 206576, "averageDailyVolume10Day": 172299, "sharesOutstanding": 57596000, "fiftyDayAverage": 25.536, "fiftyDayAverageChange": 1.4140015, "fiftyDayAverageChangePercent": 0.055372868, "twoHundredDayAverage": 21.28175, "twoHundredDayAverageChange": 5.668251, "twoHundredDayAverageChangePercent": 0.26634327, "marketCap": 1552212224, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "symbol": "6827.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 66, Shengyi 5th Rd.", "address2": "10th floor-1", "city": "Zhubei", "zip": "302", "country": "Taiwan", "phone": "886 3 591 0360", "fax": "886 3 591 0441", "website": "https://www.megaprobio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "MegaPro Biomedical Co., Ltd, a biotech company, focuses on the development of nano drugs. It also develops MPB-1523, an IOP injection that is in Phase II clinical trial for use in the treatment of hepatocellular carcinoma; and MPB-1514, an iron injection that is in Phase II clinical trial for use in the treatment of iron deficiency anemia, as well as MPB-1734, an anti-cancer drug that is in preclinical trial for the treatment of malignant tumor. The company was founded in 2014 and is based in Zhubei, Taiwan.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Jassy  Wang", "title": "Chief Exec. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}